Previous studies have suggested an association between polymorphisms in the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Most of the studies so far have been performed in Caucasoid populations. We have investigated 418 random IDDM patients and 422 healthy control subjects from three different ethnic groups; Tanzanian blacks, Norwegian Caucasians and Japanese orientals. Our data suggest that polymorphisms in the insulin gene region confer susceptibility to IDDM in Caucasians, and that a similar tendency though not statistically significant is observed among Tanzanian blacks, while no significant contribution is seen among Japanese orientals. We further demonstrate that the disease-associated genotype INS +/+ confers susceptibility independently of HLA class II alleles associated with IDDM. Compared to the contribution of particular HLA-DQ alleles in IDDM susceptibility, the additional risk conferred by the instdin gene region polymorphism is, however, small. Genotyping of the insulin gene region will therefore most probably not be a useful tool in the prediction of IDDM. [Diabetologia (1994) 
ciated with development of insulitis and diabetes in NOD mice [5] [6] [7] [8] . There have also been reports of non-HLA genes conferring susceptibility to IDDM in humans. However, apart from HLA, only polymorphisms in the insulin-IGF2 gene-region (INS) on chromosome 11, first described by Bell et al. [9] , have repeatedly shown association to IDDM. Julier et al. [10] found that the IDDM associated INS polymorphism only conferred susceptibility in HLA-DR4-positive individuals. Other studies have found that polymorphisms in INS confer risk independently of HLA genotype [11] [12] [13] . Most studies of this region have been performed in Caucasians [%17] . Reports from Japanese oriental populations on associations between 5' variable number of tandem repeats (VNTR) polymorphisms in the INS region and IDDM have not been able to show significant association [18] [19] [20] [21] [22] .
Trans-racial mapping studies have been a powerful tool in mapping which genes in the HLA region confer the primary susceptibility for IDDM [1, 23] . We have studied the contribution of newly-identified markers in the insulin gene region on IDDM susceptibility in three ethnic groups; blacks, Caucasians and orientals. We typed 418 IDDM patients and 422 healthy control subjects for three polymorphisms; 1,127 Pstl, 1,404 Fnu4 H and 1,428 Fok I that are situated 3' to the insulin gene [10] . An additional aim of this study was to evaluate the contribution of INS as a marker in IDDM prediction.
Subjects and methods
Subjects. IDDM patients and healthy control subjects from three countries and three ethnic groups were studied. The Caucasian dataset consisted of 244 randomly-selected unrelated Norwegian IDDM patients. All patients had an absolute insulin dependency (non-fasting serum C-peptide <0.1 nmol/1). The mean age of disease onset was 14 years. The distribution of HLA class II genes in 87 of these patients has been published previously [24] . A control group of 187 randomly-selected healthy subjects (130 blood donors and 57 members of the hospital staff) were included [25] . In addition 44 HLA-DR4-positive control subjects were selected from the Norwegian Bone Marrow Registry to allow comparison of INS genotype with HLA genotype. INS genotypes have been published previously for parts of this material [111.
The oriental dataset consisted of 114 randomly-selected Japanese IDDM patients and 141 randomly-selected healthy control subjects. All the patients were from the northern part of Kyushu Island and were all of Japanese ethnicbackground. The diagnosis of IDDM was made by the following criteria: non-fasting plasma C-peptide below 0.1 nmol/1 and ketoacidosis at the onset or during the disease. The mean age of disease onset was 15.1 years (range 0--47). The control subjects were randomly-selected members of medical staff and students living in the same area as the IDDM patients. HLA class II genotypes have been reported for this dataset previously [1] .
The black dataset consisted of 60 unrelated IDDM patients from Tanzania. They had all been diagnosed under the age of 30 years at the Muhimbili Medical Centre in Dar-es-Salam where they had been receiving insulin therapy for at least 1 year before the collection of blood specimens for this study. Fifty non-diabetic control subjects were selected among members of the medical Centre.
Methods. The Japanese samples were genomlcally typed for HLA class II alleles in Japan [1] , while the rest of the samples were typed in Oslo, using PCR-SSO as described elsewhere [24, 25] . To ascertain specific hybridisation, PCR-amplified DNA of 24 homozygous typing cells from the 10th International Histocompatibility Workshop (IHWS) were always processed together with the samples tested.
The typing for INS polymorphisms of the whole material was carried out in Oslo using previously described methods [11] . Briefly, the typing was performed by enzymatic digestion of PCR amplified DNA. Two PCRs were performed, amplifying DNA sequences 3' to the insulin gene. PCR amplification was performed in a 25-gl volume containing 100 ng DNA, 0. The sequences of the primers used are described elsewhere [11] . One of the PCR products was digested with Pstt. The other PCR D. Undlien et al.: Insulin gene region in IDDM product was digested with Fnu4H and Fokl. The digested PCR products were electrophoresed on a gel consisting of 3 % NuSieve GTG Agarose (FMC Bioproducts, Rockland, Me., USA) and 1.5 % Agarose (Sigma Chemical Co) and visualised by ethidium bromide staining. All samples were typed for the 1,127 Pstl polymorphism. Since a strong linkage disequilibrium has been described between the 1,127 Pstl, 1,404 Fnu4H and 1,428 Fokl polymorphisms, only 30 samples from each population, including patients and control subjects, were typed for the 1,404 Fnu4 H and the 1,428 Fokl polymorphisms [10, 11, 17, 26] .
Statistical analysis
Statistical analyses were performed by assessing relative risk by the method of Woolf. When a cell in the 2 x 2 table was zero Haldane correction was used [27] . Significance of difference was tested for by chi square or Fischer exact test when appropriate. Ap value < 0.05 was considered significant. Absolute risks were calculated using Bayes theorem [28] and using a prevalence of IDDM in the Norwegian population of 0.6 % (G. Joner, personal communication). Test for homogeneity across strata and Mantel Haenszel statistics was calculated using BMDP statistical software.
Results

INS haplotypes.
We found no exceptions to the previously described linkage disequilibrium between the three polymorphic sites investigated in either of the populations studied. By means of complete correlation between genotypes at the three loci typed for in all populations we could identify two simulated haplotypes. The one previously reported to be associated to IDDM, here called INS +, does not have the polymorphic restriction sites designated 1,127 Pstl and 1,428 Fokl respectively, but does contain the polymorphic restriction site designated 1,404 Fnu4 H. The other haplotype (INS-) shows exactly the opposite pattern at these loci. Both Norwegian control subjects and IDDM patients had a significantly higher frequency of the rare INS-haplotype compared to the other populations studied (p < 0.005; Table 1 ). The different allele frequencies observed between Tanzanian blacks and Japanese Orientals did not reach statistical significance (p = 0.2, when comparing control groups; Table 1 ). The INS-haplotype is very rare in our material and INS-/-homozygous and INS + !-heterozygous are pooled in the statistical analyses.
Norwegian Caucasians. The Norwegian dataset showed a clear association between the INS + / + genotype and IDDM giving a relative risk of 2.3,p < 0.0001 (Table 1) . This dataset was large enough to allow stratification for some HLA-DR and -DQ genotypes. There were no significant differences in the different HLA genotype groups analysed (Table 2) , nor were there significant signs of heterogeneity (p = 0.86). Thus, we found the INS + / + genotype confered virtually the same relative Table 3 the absolute risk of IDDM for those being INS + / + is given. For comparison the absolute risks of known susceptibility HLA class II genotypes are also given [1, 24, 25] . As is apparent from Table 3 , there is not a strong contribution of the IDDM associated INS + / + polymorphism to the absolute risk, compared to that associated with given HLA-DQ genes.
Discussion
The INS+/+ genotype confers susceptibility to IDDM in Norwegians while no significant association to IDDM is observed among Tanzanians and Japanese although the RR was increased in these populations also. The data suggest that INS confers susceptibility in an HLA-independent manner. The Norwegian dataset confirms previous studies that have shown an increased frequency of the INS +/+ genotype in IDDM patients of Caucasoid origin [9] [10] [11] [12] [13] [14] [15] [16] [17] . The same association seems to be present among Tanzanian blacks, where the RR for INS +/+ is somewhat higher than in the Norwegian population, but the total numbers of patients and control subjects are much smaller and do not show statistically significant p value. A previous study in American blacks failed to show any significant association between INS genotypes and IDDM [29] . The sample size in this study was, however, small (n = 27).
The Japanese population has a higher frequency of the INS +/+ genotype both among control subjects and IDDM patients than the other populations studied here. The relative risk is, however, comparable to that of the Norwegian dataset as well as that of other studies in Caucasians. The difference in frequency between patients and control subjects is, however, not significant in this population. This could reflect disease heterogeneity. The very high frequency of INS + / + in Japanese is in agreement with studies applying the 5'VNTR polymorphism to assess the INS genotype [18] [19] [20] [21] [22] . None of these previous studies have shown any contribution of the INS region to IDDM susceptibility among Japanese subjects. Although there is no significant association between INS polymorphisms and IDDM among Japanese either in this or in previous studies, it cannot be ruled out that the INS region contributes to IDDM susceptibility among Japanese subjects. Firstly, the frequency of INS + / + is very high among Japanese control subjects making a very large sample size necessary to detect an association. Secondly, the biologically important polymorphism in the INS region has to be identified and association studies performed before one can conclude that there is lack of association. Lucassen et al. [17] have most recently identified a cluster of polymorphisms, in a 4.1 kb region encompassing the insulin gene, which among Caucasians are in strong linkage disequilibrium making it difficult to pin-point the biologically important one. Several of these polymorphisms have not been studied among Japanese. The high frequency of INS + / + in Japanese.where the D. Undlien et al.: Insulin gene region in IDDM incidence of IDDM is low, may suggest that this polymorphism contributes little to susceptibility to the disease. In addition previous studies have shown that IDDM in Japanese subjects is associated with different HLA-DQ genes than in Caucasians [30, 31] .
Regarding HLA INS associations we find no support for the previous report of INS + / + conferring susceptibility only in HLA-DR4-positive individuals. There are no differences in allele frequencies of INS + in DR4-positive and DR4-negative patients (89% in both groups) and there is no significant heterogeneity. Thus, the slightly smaller RR obtained for DR4-negative patients in this study is probably due to chance and the lack of significant p value for this group may be due to insufficient sample size. The DR4-DQB 1"0302 haplotype is found in 76 % of Norwegian IDDM patients, and no DR4-DQBI*0302 negative genotypes confer significant risk for IDDM among Norwegians [24] . The INS genotypes from some of the Norwegian material have been reported previously in a study that also included British patients, control subjects and multiplex families [11] . In the present study the material is, however, enlarged and HLA-DQ genotypes are included besides the HLA-DR genotypes reported previously. Our data are in agreement with other reports showing no INS -HLA interactions [11] [12] [13] and thus are in conflict with the report by Julier et al. [10] . We cannot, however, completely rule out the possibility that the risk conferred by INS is slightly higher among DR4-positive individuals as suggested byLucassen et al. [17] .
The finding that INS confers susceptibility to IDDM independently of HLA is of great interest both theoretically and from a clinical point of view. A marker that confers susceptibility independently of HLA may be of greater value in identifying persons at high risk of developing IDDM. When we add the risk conferred by HLA and INS, the increase in absolute risk for IDDM is, however, small. This indicates that with the current markers used to assess INS genotypes, INS will not be very helpful in screening for IDDM risk.
In conclusion our data suggest that INS confers susceptibility to IDDM development in Caucasoids and that this effect is independent of HLA genotype. A similar, though not significant, tendency is observed among Tanzanian blacks. We find, however, that the INS polymorphism does not add greatly to the risk associated with given HLA polymorphisms.
